Search hospitals > Oregon > Portland
Providence Saint Vincent Medical Center
Claim this profilePortland, Oregon 97225
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Pancreatic Cancer
485 reported clinical trials
25 medical researchers
Summary
Providence Saint Vincent Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Pancreatic Cancer and other specialties. Providence Saint Vincent Medical Center is involved with conducting 485 clinical trials across 631 conditions. There are 25 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Alison K. ConlinProvidence Portland Medical Center6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
107 reported clinical trials
183 drugs studied
Charles W. DrescherProvidence Portland Medical Center8 years of reported clinical research
Studies Breast Cancer
Studies Non-Small Cell Lung Cancer
53 reported clinical trials
99 drugs studied
Rachel Sanborn, MDProvidence Portland Medical Center6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
43 reported clinical trials
68 drugs studied
Nitya AlluriProvidence Portland Medical Center2 years of reported clinical research
Studies Uterine Cancer
Studies Endometrial Adenocarcinoma
28 reported clinical trials
79 drugs studied
Clinical Trials running at Providence Saint Vincent Medical Center
Lung Cancer
Breast Cancer
Prostate Cancer
Breast cancer
Kidney Cancer
Bladder Cancer
Bladder Carcinoma
Pancreatic Cancer
Cancer
Oropharyngeal Carcinoma
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting2 awards Phase 38 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Providence Saint Vincent Medical Center?
Providence Saint Vincent Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Pancreatic Cancer and other specialties. Providence Saint Vincent Medical Center is involved with conducting 485 clinical trials across 631 conditions. There are 25 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.
Where is Providence Saint Vincent Medical Center located?
**Providence Saint Vincent Medical Center**
- **Address:** 9205 SW Barnes Rd, Portland, OR 97225
- **Directions:** For real-time directions based on current traffic updates, use Waze. For step-by-step guidance, MapQuest is recommended.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Providence Saint Vincent Medical Center, contact a financial counselor at 855-229-6466, available Monday to Friday, 7 a.m. to 5:30 p.m. PT. In-person appointments with a financial counselor are also available, or you can visit a billing office at your local Providence facility.
What insurance does Providence Saint Vincent Medical Center accept?
Providence Saint Vincent Medical Center accepts a wide range of insurance plans, including commercial insurance, managed Medicaid, Medicare Advantage, and Health Insurance Exchange plans. They are contracted with most major insurance carriers, offering in-network rates for high-quality care. Accepted plans include, but are not limited to, Health Net Dual Eligible, LA Care Medicare Advantage, Anthem Blue Cross HMO Covered California, and various Blue Shield and Health Net Covered California plans.
What awards or recognition has Providence Saint Vincent Medical Center received?
Providence St. Vincent Medical Center, located in Portland, Oregon, is a six-time Magnet designated hospital, the highest national honor for professional nursing practice. It has been named one of America's 50 Best Hospitals by Healthgrades for three consecutive years and recognized as a Top 100 hospital by Solucient 10 times. The hospital is part of Providence in Oregon, a comprehensive not-for-profit network including hospitals, health plans, physicians, clinics, and affiliated health services.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.